top of page

Blood test identified as a good biomarker for idiopathic PAH

A relatively simple, inexpensive, and minimally invasive test for idiopathic pulmonary arterial hypertension (IPAH) would aid in the diagnosis of this disease. This study found that levels of the NOTCH3 extracellular domain (NOTCH3-ECD) shed into blood serum could be used as a biomarker for IPAH. They found that NOTCH3-ECD levels did correlate with the presence and severity of IPAH.


 
 
 

Recent Posts

Screening for PH in ILD

This study looked at how to better detect pulmonary hypertension (PH) in people with interstitial lung disease (ILD), since PH often makes breathing problems, quality of life, and survival worse. Rese

 
 
 
Biomarkers identified for high-altitude PH

This study looked at which proteins and metabolic biomarkers might be associated with the development of high-altitude pulmonary hypertension (PH). Looking at data from China, from rat tissues, and fr

 
 
 
Smoking delays PAH diagnosis, but not CTEPH

Researchers looked at whether cigarette smoking affected the diagnosis and disease progression of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension

 
 
 

2 Comments


vbb64316
5 days ago

The detection of a biomarker for IPAH wacky flip through blood testing is a very positive sign, as early diagnosis always plays a crucial role in treatment and improving the quality of life for patients.

Like

That’s really encouraging-having a simple sprunki game blood test that can reflect both presence and severity could make a big difference for earlier diagnosis and monitoring.

Like

PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Charitable Registration # 872050224RR0001

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe   |   Powered by raisin

bottom of page